Process for forming amorphous atorvastatin

Details Process for forming amorphous atorvastatin Process for forming amorphous atorvastatin

2004-04-20

2010-02-02

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S537000

Reexamination Certificate

active

07655692

ABSTRACT:
Forming amorphous atorvastatin comprises the steps of dissolving atorvastatin in a hydroxylic solvent, followed by rapidly evaporating the solvent. In another aspect, a composition comprises particles of amorphous atorvastatin and a core.

REFERENCES:
patent: 4681893 (1987-07-01), Roth
patent: 5003080 (1991-03-01), Butler et al.
patent: 5097045 (1992-03-01), Butler et al.
patent: 5103024 (1992-04-01), Millar et al.
patent: 5124482 (1992-06-01), Butler et al.
patent: 5149837 (1992-09-01), Butler et al.
patent: 5155251 (1992-10-01), Butler et al.
patent: 5216174 (1993-06-01), Butler et al.
patent: 5245047 (1993-09-01), Butler et al.
patent: 5248793 (1993-09-01), Millar et al.
patent: 5273995 (1993-12-01), Roth
patent: 5280126 (1994-01-01), Butler et al.
patent: 5298627 (1994-03-01), Butler et al.
patent: 5342952 (1994-08-01), Butler et al.
patent: 5397792 (1995-03-01), Butler et al.
patent: 5446054 (1995-08-01), Butler et al.
patent: 5470981 (1995-11-01), Butler et al.
patent: 5489690 (1996-02-01), Butler et al.
patent: 5489691 (1996-02-01), Butler et al.
patent: 5510488 (1996-04-01), Butler et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 5969156 (1999-10-01), Briggs et al.
patent: 5998633 (1999-12-01), Jacks et al.
patent: 6087511 (2000-07-01), Lin et al.
patent: 6121461 (2000-09-01), McKenzie
patent: 6126971 (2000-10-01), Mills et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6274740 (2001-08-01), Lin et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: 6433213 (2002-08-01), Bosch et al.
patent: 6476235 (2002-11-01), Butler et al.
patent: 6531507 (2003-03-01), Pflaum et al.
patent: 6605729 (2003-08-01), Byrn et al.
patent: 2003/0109584 (2003-06-01), Pflaum et al.
patent: 0 848 705 (1997-02-01), None
patent: 1 027 886 (2000-08-01), None
patent: WO 97/03960 (1997-02-01), None
patent: WO 00/71116 (2000-11-01), None
patent: WO 00/72825 (2000-12-01), None
patent: WO 01/28999 (2001-04-01), None
patent: WO 01/36384 (2001-05-01), None
patent: WO-01/42209 (2001-06-01), None
patent: WO 01/42209 (2001-06-01), None
patent: WO 02/41834 (2002-05-01), None
patent: WO 02/43667 (2002-06-01), None
patent: WO 02/43732 (2002-06-01), None
patent: WO 02/051385 (2002-07-01), None
patent: WO 02/051804 (2002-07-01), None
patent: WO 02/057228 (2002-07-01), None
patent: WO 02/057229 (2002-07-01), None
patent: WO 02/057274 (2002-07-01), None
patent: WO 02/059087 (2002-08-01), None
patent: WO 02/062824 (2002-08-01), None
patent: WO 02/083637 (2002-10-01), None
patent: WO 02/083638 (2002-10-01), None
patent: WO 03/011826 (2003-02-01), None
patent: WO 03/018547 (2003-03-01), None
patent: WO 03/050085 (2003-06-01), None
patent: WO 03/070702 (2003-08-01), None
patent: WO 2004/022053 (2004-03-01), None
Gaspar et al, “Spray drying technology for better API crystals,” Process Development, 2004.
Takemoto, M., et al, “Statinsas antioxidant therapy for preventing cardiac myocyte hypertrophy”, The Journal of Clinical Investigation, Nov. 2001, vol. 108, No. 10, pp. 1429-1437.
Konno, T., Chem. Pharm. Bull., 1990, vol. 38, pp. 2003-2007.

Affiliated with

Also associated with

Rating

Process for forming amorphous atorvastatin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for forming amorphous atorvastatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for forming amorphous atorvastatin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4207746